+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Precision Medicine Software Market - Global Outlook & Forecast 2022-2027

  • PDF Icon

    Report

  • 249 Pages
  • January 2022
  • Region: Global
  • Arizton
  • ID: 5530301
UP TO OFF until Sep 30th 2022
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The precision medicine software market size was valued at USD 1,344.28 million in 2021 and is expected to reach USD 2,657.21 million by 2027, growing at a CAGR of 12.03% during the forecast period. Favorable government initiatives and the adoption of big data analytics and related software continue to drive precision medicine software industry growth. Precision medicine software is one of the fast-growing healthcare systems IT industry segments, driven predominantly by genomics, drug discovery & development, clinical research, and big data analytics. Start-ups are leveraging many software and machine learning algorithms to help solve major and complex problems such as reducing R&D activities timeline and billion dollars of expenditure during drug development processes.

The following factors are likely to contribute to the growth of the precision medicine software market:

  • Technological Advancements for Improvement of Precision Medicine Delivery
  • Increased Adoption of Cloud-Based Platform
  • The emergence of Local & Regional Start-Ups
  • Prevalence of Cancer, Genetic and Rare Diseases
  • Increased Partnership Among Software and Pharmaceutical Companies

KEY HIGHLIGHTS

  • Blockchain technology, which works on shared ledgers and distributed networks, can ensure the data is secured and used ethically while prohibiting mishandling. Thus, blockchain technology has a huge scope in the precision medicine market.
  • Start-ups and scaleups are developing research platforms and techniques to better understand the underlying causes of cancer. For instance, US-America start-up OncXerna creates an RNA expression biomarker panel that permits clinical researchers to develop algorithms for effective treatment using RNA signature derived from biomarker panels.
  • AI leverages sophisticated computation and deep learning to overcome the obstacles involved in sizeable disparate data sets and generate insights to enable the system to learn and reason. Over the last few years, AI approaches have been used in neurodevelopmental disorders, specifically autism spectrum disorder, epileptic encephalopathy, intellectual disability, attention deficit hyperactivity disorder (ADHD), and rare genetic disorders.

PRECISION MEDICINE SOFTWARE MARKET SEGMENTS


The precision medicine software market is segmented based on:

  • Deployment
  • Application
  • End-user
  • Geography

PRECISION MEDICINE SOFTWARE MARKET SEGMENTATION

  • The on-cloud segment will witness an absolute growth of more than 100% in the forecast period. Cloud technology supports the industry with an agile and mountable provider engagement model. This provides better outcomes by pushing crucial information to clinicians while pulling vital, real-world insight back from key experts in the field.
  • Precision oncology has the highest share in Precision medicine practices by application. Oncology is the leading and fastest-growing therapeutic area in the life sciences industry. New treatments are being established at a remarkable pace, with more than 1100 oncology therapeutics in clinical development in the US alone.

Market segmentation by Deployment

  • On-Premises
  • Cloud

Market segmentation by Application

  • Precision Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Others

Market segmentation by End User

  • Healthcare Providers
  • Research Labs
  • Pharma & Biotech Companies

GEOGRAPHICAL OUTLOOK

  • North America: North America made remarkable progress post the Human Genome Project in genome sequencing and precision medicine. The region is actively engaged in developing and commercializing cell and gene therapies with ICT and genome sequencing. This will drive demand in the precision medicine software industry.
  • Europe: The European Commission has been a driver for developing PM approaches to be readily implemented in healthcare practice. Its efforts started in 2010 with a series of workshops exploring different research areas that can contribute to developing precision medicine.
  • APAC: The region will likely witness a dramatic rise and innovation in precision medicine. China has already begun to make significant progress in genomics research, announcing its precision medicine initiative in 2016 with an investment of around USD 9 billion by 2030.

Market segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Turkey
  • Saudi Arabia

VENDOR LANDSCAPE

  • The key players in the precision medicine software market are Syapse, AccessDx Laboratory, Fabric Genomics, Foundation Medicine, Intel, and International Business Machines (IBM).
  • Companies are resolving to inorganic growth approaches. AccessDx Holdings acquired 2bPrecise to create the industry’s most advanced precision medicine enablement solution.

Key Vendors

  • AccessDx Laboratory
  • Fabric Genomics
  • Foundation Medicine
  • Intel
  • IBM
  • Syapse

Other Prominent Vendors

  • GenomOncology
  • Koninklijke Philips
  • LifeOmic
  • NantHealth
  • PhenoTips
  • PierianDx
  • Qiagen
  • Roper Technologies
  • SOPHiA GENETICS
  • Translational Software

KEY QUESTIONS ANSWERED:


1. What is the global precision medicine software market size and growth rate?
2. What are the key factors supporting the growth of the global precision medicine software market?
3. Who are the key players operating in the global precision medicine software market?
4. What are the key trends in the precision medicine software market?
5. Which segment will offer the opportunity for growth between 2021 and 2026?

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market By Deployment
4.3.2 Market By Application
4.3.3 Market By End-User
4.3.4 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Technological Advances In Precision Medicine Delivery
8.2 Increased Adoption Of Cloud-Based Platforms
8.3 Emergence Of Local & Regional Start-UPS
8.4 Artificial Intelligence In Precision Medicine
9 Market Growth Enablers
9.1 High Prevalence Of Cancer, Genetic, & Rare Diseases
9.2 Increased Partnerships Among Software & Pharmaceutical Companies
9.3 Paradigm Shift Toward Tailored Disease Treatment
10 Market Growth Restraints
10.1 High R&D & Implementation Cost Of Precision Medicine
10.2 Dearth Of Skilled Professionals
10.3 Lack Of Security & Storage For Large Volumes Of Sequenced Data
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geography Insights
11.2.2 Deployment Insights
11.2.3 Application Insights
11.2.4 End-User Insights
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry
12 Deployment
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 On-Premise
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Market By Geography
12.4 Cloud
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Market By Geography
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Precision Oncology
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market By Geography
13.4 Pharmacogenomics
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market By Geography
13.5 Rare Disease
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market By Geography
13.6 Others
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Market By Geography
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Healthcare Providers
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market By Geography
14.4 Research Labs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market By Geography
14.5 Pharma & Biotech Companies
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market By Geography
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Deployment
16.3.1 Market Size & Forecast
16.4 Application
16.4.1 Market Size & Forecast
16.5 End-User
16.5.1 Market Size & Forecast
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Deployment
17.3.1 Market Size & Forecast
17.4 Application
17.4.1 Market Size & Forecast
17.5 End-User
17.5.1 Market Size & Forecast
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Deployment
18.3.1 Market Size & Forecast
18.4 Application
18.4.1 Market Size & Forecast
18.5 End-User
18.5.1 Market Size & Forecast
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 India: Market Size & Forecast
18.6.4 Australia: Market Size & Forecast
18.6.5 South Korea: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Deployment
19.3.1 Market Size & Forecast
19.4 Application
19.4.1 Market Size & Forecast
19.5 End-User
19.5.1 Market Size & Forecast
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Deployment
20.3.1 Market Size & Forecast
20.4 Application
20.4.1 Market Size & Forecast
20.5 End-User
20.5.1 Market Size & Forecast
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 Saudi Arabia: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
22 Key Company Profiles
22.1 ACCESSDX LABORATORY
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 FABRIC GENOMICS
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 FOUNDATION MEDICINE
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 INTEL
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 IBM
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 SYAPSE
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
23 Other Prominent Vendors
23.1 GENOMONCOLOGY
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 KONINKLIJKE PHILIPS
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 LIFEOMIC
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 NANTHEALTH
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 PHENOTIPS
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 PIERIANDX
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 QIAGEN
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 ROPER TECHNOLOGIES
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 SOPHIA GENETICS
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 TRANSLATIONAL SOFTWARE
23.10.1 Business Overview
23.10.2 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market By Geography
25.1.1 North America: By Deployment
25.1.2 North America: By Application
25.1.3 North America: By End-User
25.1.4 Europe: By Deployment
25.1.5 Europe: By Application
25.1.6 Europe: By End-User
25.1.7 APAC: By Deployment
25.1.8 APAC: By Application
25.1.9 APAC: By End-User
25.1.10 Latin America: By Deployment
25.1.11 Latin America: By Application
25.1.12 Latin America: By End-User
25.1.13 Middle East & Africa: By Deployment
25.1.14 Middle East & Africa: By Application
25.1.15 Middle East & Africa: By End-User
25.2 Deployment
25.2.1 On-Premises
25.2.2 Cloud
25.3 Application
25.3.1 Precision Oncology
25.3.2 Pharmacogenomics
25.3.3 Rare Diseases
25.3.4 Others
25.4 End-User
25.4.1 Healthcare Facilities
25.4.2 Research Labs
25.4.3 Pharma & Biotech Companies
26 Appendix
26.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Precision Medicine Software Market
Exhibit 2 Market Size Calculation Approach 2021
Exhibit 3 Impact of Technological Advances in Precision Medicine Delivery
Exhibit 4 Impact of Increased Adoption of Cloud-based Platforms
Exhibit 5 Cancer Diagnoses & Treatment with Cloud-based Platforms
Exhibit 6 Impact of Emergence of Local & Regional Start-ups
Exhibit 7 Impact of Artificial Intelligence in Precision Medicine
Exhibit 8 Dimensions of Synergy Between AI & Precision Medicine
Exhibit 9 Impact of High Prevalence of Cancer, Genetic, & Rare Diseases
Exhibit 10 Global Rare Diseases Statistics Overview
Exhibit 11 Prevalence Rate of Selected Rare Diseases Worldwide as of 2017 (per 100,000 population)
Exhibit 12 Impact of Increased Partnerships Among Software & Pharmaceutical Companies
Exhibit 13 Impact of Paradigm Shift Toward Tailored Disease Treatment
Exhibit 14 Impact of High R&D & Implementation Cost of Precision Medicine
Exhibit 15 Impact of Dearth of Skilled Professionals
Exhibit 16 Impact of Lack of Security & Storage for Large Volumes of Sequenced Data
Exhibit 17 Key Growth Drivers & Trends in Precision Medicine Software Market
Exhibit 18 Global Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 19 Global Precision Medicine Software Market by Geography
Exhibit 20 Global Precision Medicine Software Market by Deployment
Exhibit 21 Global Precision Medicine Software Market by Application
Exhibit 22 Global Precision Medicine Software Market by End-user
Exhibit 23 Five Forces Analysis 2021
Exhibit 24 Incremental Growth by Deployment 2021 & 2027
Exhibit 25 Global Precision Medicine Software Market by Deployment Type
Exhibit 26 Global Precision Medicine Software Market by Deployment Type: Incremental Growth
Exhibit 27 Global Precision Medicine Software Market by Deployment Type: Absolute Growth
Exhibit 28 Global On-premise Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 29 Global On-premise Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 30 Incremental Growth by Geography 2021 & 2027
Exhibit 31 Advantages of Cloud Implementation
Exhibit 32 Global Cloud Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 33 Global Cloud Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 34 Incremental Growth by Geography 2021 & 2027
Exhibit 35 Incremental Growth by Application 2021 & 2027
Exhibit 36 Global Precision Medicine Software Market by Application
Exhibit 37 Global Precision Medicine Software Market by Application: Incremental Growth
Exhibit 38 Global Precision Medicine Software Market by Application: Absolute Growth
Exhibit 39 Global Precision Oncology Medicine Software Market: Incremental & Absolute Growth
Exhibit 40 Global Precision Oncology Medicine Software Market 2021-2027 ($ million)
Exhibit 41 Incremental Growth by Geography 2021 & 2027
Exhibit 42 Inter-individual Variability with Drug Response
Exhibit 43 Global Pharmacogenomics Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 44 Global Pharmacogenomics Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 45 Incremental Growth by Geography 2021 & 2027
Exhibit 46 Global Rare Diseases Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 47 Global Rare Disease Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 48 Incremental Growth by Geography 2021 & 2027
Exhibit 49 Global Other Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 50 Global Other Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 51 Incremental Growth by Geography 2021 & 2027
Exhibit 52 Incremental Growth by End-user 2021 & 2027
Exhibit 53 Global Precision Medicine Software Market by End-user
Exhibit 54 Global Precision Medicine Software Market by End-user: Incremental Growth
Exhibit 55 Global Precision Medicine Software Market by End-user: Absolute Growth
Exhibit 56 Global Healthcare Facilities Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 57 Global Healthcare Providers Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 58 Incremental Growth by Geography 2021 & 2027
Exhibit 59 Global Research Labs Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 60 Global Research Labs Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 61 Incremental Growth by Geography 2021 & 2027
Exhibit 62 Global Pharma & Biotech Companies Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 63 Global Pharma & Biotech Companies Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 64 Incremental Growth by Geography 2021 & 2027
Exhibit 65 Incremental Growth by Geography 2021 & 2027
Exhibit 66 Global Precision Medicine Software Market by Geography
Exhibit 67 Global Precision Medicine Software Market by Geography: Incremental Growth
Exhibit 68 Global Precision Medicine Software Market by Geography: Absolute Growth
Exhibit 69 North America Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 70 North America Precision Medicine Software Market: Key Countries 2021
Exhibit 71 North America Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 72 Incremental Growth in North America 2021 & 2027
Exhibit 73 US Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 74 Canada Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 75 Key Objectives of IC PERMED
Exhibit 76 Europe Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 77 Europe Precision Medicine Software Market: Key Countries 2021
Exhibit 78 Europe Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 79 Incremental Growth in Europe 2021 & 2027
Exhibit 80 Germany Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 81 France Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 82 Precision Medicine Software Market in UK 2021-2027 ($ million)
Exhibit 83 Precision Medicine Software Market in Italy 2021-2027 ($ million)
Exhibit 84 Precision Medicine Software Market in Spain 2021-2027 ($ million)
Exhibit 85 APAC Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 86 APAC Precision Medicine Software Market: Key Countries 2021
Exhibit 87 APAC Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 88 Incremental Growth in APAC 2021 & 2027
Exhibit 89 Precision Medicine Software Market in China 2021-2027 ($ million)
Exhibit 90 Precision Medicine Software Market in Japan 2021-2027 ($ million)
Exhibit 91 Precision Medicine Software Market in India 2021-2027 ($ million)
Exhibit 92 Precision Medicine Software Market in Australia 2021-2027 ($ million)
Exhibit 93 Precision Medicine Software Market in South Korea 2021-2027 ($ million)
Exhibit 94 Latin America Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 95 Latin America Precision Medicine Software Market: Key Countries 2021
Exhibit 96 Latin America Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 97 Incremental Growth in Latin America 2021 & 2027
Exhibit 98 Brazil Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 99 Mexico Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 100 Middle East & Africa Precision Medicine Software Market: Incremental & Absolute Growth
Exhibit 101 Middle East & Africa Precision Medicine Software Market: Key Countries 2021
Exhibit 102 Middle East &Africa Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 103 Incremental Growth in Middle East &Africa 2021 & 2027
Exhibit 104 Turkey Precision Medicine Software Market 2021-2027 ($ million)
Exhibit 105 Precision Medicine Software Market in Saudi Arabia 2021-2027 ($ million)
Exhibit 106 Intel: Annual Revenues 2018-2020 ($ billion)
Exhibit 107 Intel: Segment Revenue 2019-2020 ($ billion)
Exhibit 108 International Business Machines: Annual Revenue 2018-2020 ($ million)
Exhibit 109 International Business Machines: Annual Revenue 2018-2020 ($ million)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2015-2021
Table 3 Top 5 Precision Medicine Start-ups
Table 4 Global On-premise Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 5 Global On-premise Precision Medicine Software Market by Geography 2021-2027 (%)
Table 6 Global Cloud Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 7 Global Cloud Precision Medicine Software Market by Geography 2021-2027 (%)
Table 8 Global Precision Oncology Medicine Software Market by Geography 2021-2027 ($ million)
Table 9 Global Precision Oncology Medicine Software Market by Geography 2021-2027 (%)
Table 10 Global Pharmacogenomics Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 11 Global Precision Medicine Software Market by Pharmacogenomics: Geography 2021-2027 (%)
Table 12 Global Rare Disease Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 13 Global Rare Disease Precision Medicine Software Market by Geography 2021-2027 (%)
Table 14 Global Other Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 15 Global Other Precision Medicine Software Market by Geography 2021-2027 (%)
Table 16 Global Healthcare Facilities Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 17 Global Healthcare Facilities Precision Medicine Software Market by Geography 2021-2027 (%)
Table 18 Global Research Labs Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 19 Global Research Labs Precision Medicine Software Market by Geography 2021-2027 (%)
Table 20 Global Pharma & Biotech Companies Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 21 Global Pharma & Biotech Companies Precision Medicine Software Market by Geography 2021-2027 (%)
Table 22 North America Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 23 North America Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 24 North America Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 25 North America Precision Medicine Software Market by Application 2021-2027 (%)
Table 26 North America Precision Medicine Software Market by End-user2021-2027 ($ million)
Table 27 North America Precision Medicine Software Market by End-user 2021-2027 (%)
Table 28 Europe Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 29 Europe Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 30 Europe Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 31 Europe Precision Medicine Software Market by Application 2021-2027 (%)
Table 32 Europe Precision Medicine Software Market by End-user2021-2027 ($ million)
Table 33 Europe Precision Medicine Software Market by End-user 2021-2027 (%)
Table 34 APAC Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 35 APAC Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 36 APAC Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 37 APAC Precision Medicine Software Market by Application 2021-2027 (%)
Table 38 APAC Precision Medicine Software Market by End-user2021-2027 ($ million)
Table 39 APAC Precision Medicine Software Market by End-user 2021-2027 (%)
Table 40 Latin America Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 41 Latin America Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 42 Latin America Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 43 Latin America Precision Medicine Software Market by Application 2021-2027 (%)
Table 44 Latin America Precision Medicine Software Market by End-user2021-2027 ($ million)
Table 45 Latin America Precision Medicine Software Market by End-user 2021-2027 (%)
Table 46 Middle East &Africa Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 47 Middle East &Africa Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 48 Middle East &Africa Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 49 Middle East &Africa Precision Medicine Software Market by Application 2021-2027 (%)
Table 50 Middle East &Africa Precision Medicine Software Market by End-user2021-2027 ($ million)
Table 51 Middle East &Africa Precision Medicine Software Market by End-user 2021-2027 (%)
Table 52 ACCESSDX Laboratory: Major Product Offerings
Table 53 Fabric Genomics: Major Product Offerings
Table 54 Foundation Medicine: Major Product Offerings
Table 55 Intel: Major Product Offerings
Table 56 International Business Machines: Major Product Offerings
Table 57 SYAPSE: Major Product Offerings
Table 58 GENOMONCOLOGY: Major Product Offerings
Table 59 KONINKLIJKE Philips: Major Product Offerings
Table 60 LIFEOMIC: Major Product Offerings
Table 61 NANTHEALTH: Major Product Offerings
Table 62 PHENOTIPS: Major Product Offerings
Table 63 PIERIANDX: Major Product Offerings
Table 64 Qiagen: Major Product Offerings
Table 65 Roper Technologies: Major Product Offerings
Table 66 SOPHIA GENETICS: Major Product Offerings
Table 67 Translational Software: Major Product Offerings
Table 68 Global Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 69 Global Precision Medicine Software Market by Geography 2021-2027 (%)
Table 70 North America Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 71 North America Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 72 North America Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 73 North America Precision Medicine Software Market by Application 2021-2027 (%)
Table 74 North America Precision Medicine Software Market by End-user 2021-2027 ($ million)
Table 75 North America Precision Medicine Software Market by End-user 2021-2027 (%)
Table 76 Europe Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 77 Europe Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 78 Europe Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 79 Europe Precision Medicine Software Market by Application 2021-2027 (%)
Table 80 Europe Precision Medicine Software Market by End-user 2021-2027 ($ million)
Table 81 Europe Precision Medicine Software Market by End-user 2021-2027 (%)
Table 82 APAC Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 83 APAC Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 84 APAC Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 85 APAC Precision Medicine Software Market by Application 2021-2027 (%)
Table 86 APAC Precision Medicine Software Market by End-user 2021-2027 ($ million)
Table 87 APAC Precision Medicine Software Market by End-User 2021-2027 (%)
Table 88 Latin America Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 89 Latin America Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 90 Latin America Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 91 Latin America Precision Medicine Software Market by Application 2021-2027 (%)
Table 92 Latin America Precision Medicine Software Market by End-user 2021-2027 ($ million)
Table 93 Latin America Precision Medicine Software Market by End-user 2021-2027 (%)
Table 94 Middle East & Africa Precision Medicine Software Market by Deployment 2021-2027 ($ million)
Table 95 Middle East & Africa Precision Medicine Software Market by Deployment 2021-2027 (%)
Table 96 Middle East & Africa Precision Medicine Software Market by Application 2021-2027 ($ million)
Table 97 Middle East & Africa Precision Medicine Software Market by Application 2021-2027 (%)
Table 98 Middle East & Africa Precision Medicine Software Market by End-user 2021-2027 ($ million)
Table 99 Middle East & Africa Precision Medicine Software Market by End-user 2021-2027 (%)
Table 100 Global On-premises Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 101 Global On-premises Precision Medicine Software Market by Geography 2021-2027 (%)
Table 102 Global Cloud Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 103 Global Cloud Precision Medicine Software Market by Geography 2021-2027 (%)
Table 104 Global Precision Oncology Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 105 Global Precision Oncology Precision Medicine Software Market by Geography 2021-2027 (%)
Table 106 Global Pharmacogenomics Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 107 Global Pharmacogenomics Precision Medicine Software Market by Geography 2021-2027 (%)
Table 108 Global Rare Diseases Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 109 Global Rare Diseases Precision Medicine Software Market by Geography 2021-2027 (%)
Table 110 Global Other Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 111 Global Other Precision Medicine Software Market by Geography 2021-2027 (%)
Table 112 Global Healthcare Facilities Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 113 Global Healthcare Facilities Precision Medicine Software Market by Geography 2021-2027 (%)
Table 114 Global Research Labs Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 115 Global Research Labs Precision Medicine Software Market by Geography 2021-2027 (%)
Table 116 Global Pharma & Biotech Companies Precision Medicine Software Market by Geography 2021-2027 ($ million)
Table 117 Global Pharma & Biotech Companies Precision Medicine Software Market by Geography 2021-2027 (%)

Companies Mentioned

  • AccessDx Laboratory
  • Fabric Genomics
  • Foundation Medicine
  • Intel
  • IBM
  • Syapse
  • GenomOncology
  • Koninklijke Philips
  • LifeOmic
  • NantHealth
  • PhenoTips
  • PierianDx
  • Qiagen
  • Roper Technologies
  • SOPHiA GENETICS
  • Translational Software

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...